Which condition is a contraindication for Hespan and Hextend?

Which condition is a contraindication for Hespan and Hextend?

• A. Sepsis
• B. Severe liver disease
• C. Dehydration
• D. Normal liver function

Answer: (A)

Hetastarch solutions used for volume expansion are not benign in every setting; they can interfere with coagulation and kidney function. In patients with sepsis, these issues are already a major concern—sepsis often involves coagulopathy and reduced renal function. Using hydroxyethyl starch in this context can worsen bleeding risks and kidney injury, and clinical evidence has shown worse outcomes in septic patients treated with these starch colloids. That combination of harm in sepsis is why sepsis is a contraindication for Hespan and Hextend. Dehydration isn’t a contraindication by itself, and normal liver function doesn’t create a contraindication either. Severe liver disease could complicate the picture due to potential accumulation and hepatic effects, but the specific contraindication highlighted here is the sepsis scenario, which poses the clearest risk with these products.

Hetastarch solutions used for volume expansion are not benign in every setting; they can interfere with coagulation and kidney function. In patients with sepsis, these issues are already a major concern—sepsis often involves coagulopathy and reduced renal function. Using hydroxyethyl starch in this context can worsen bleeding risks and kidney injury, and clinical evidence has shown worse outcomes in septic patients treated with these starch colloids. That combination of harm in sepsis is why sepsis is a contraindication for Hespan and Hextend.

Dehydration isn’t a contraindication by itself, and normal liver function doesn’t create a contraindication either. Severe liver disease could complicate the picture due to potential accumulation and hepatic effects, but the specific contraindication highlighted here is the sepsis scenario, which poses the clearest risk with these products.